Loading
Machines that watch the tumour while treating it: first with MRI inside the treatment machine, then with a PET scanner that steers the beam from the tumour's own signal. Dated from the FDA records.
ViewRay's first system, cleared in May 2012 (K111862), combined MRI with three cobalt-60 sources. The MRIdian Linac replaced cobalt with a linac in 2017 (K162393) and was redesigned in 2021 (K212958). Elekta Unity, a 7 MV linac rotating around a 1.5 tesla MRI, was cleared in December 2018 (K182076) with MRIdian as predicate. ViewRay filed for Chapter 11 in July 2023; ViewRay Systems, established in February 2024 after acquiring its assets, sells the MRIdian A3i. RefleXion's X1 was cleared in 2020 (K190978) and its PET-guided SCINTIX therapy by De Novo in February 2023 (DEN220014) for lung and bone tumours, and the X2 (K252071, December 2025) widened the PET field of view from 5.3 to 21.5 cm.
The ViewRay System (K111862, May 2012) paired a low-field MRI with three cobalt-60 heads so soft tissue could be seen during treatment. Cobalt limited beam sharpness and dose rate.
The MRIdian Linac (K162393, February 2017) replaced cobalt with a linac; Elekta Unity (K182076, December 2018) put a 7 MV linac around a 1.5 tesla MRI. Daily online adaptation and gating on soft tissue became routine at the centres that bought them, and MIRAGE showed less toxicity with MR-guided prostate stereotactic treatment.
ViewRay filed for Chapter 11 in July 2023. ViewRay Systems, established on 6 February 2024 after acquiring the assets, designs, makes and sells the MRIdian A3i, described as adding brain treatment and real-time 3D tissue tracking.
RefleXion's X1 (K190978, 2020) added a PET subsystem to a ring linac; its SCINTIX biology-guided therapy was authorised by De Novo in February 2023 (DEN220014) for tumours in lung and bone, creating a new device type. The X2 (K252071, December 2025) uses four detector rows instead of one, widening the PET field from 5.3 to 21.5 cm.
Throughput and cost limit both approaches, and whether daily adaptation improves cure rather than only toxicity is still being tested. A coordinated evidence programme for adaptive radiotherapy is proposed in OnCo.
Every era's records, trial outcomes and papers, and every watch item, as JSON.
Loading this step…
Loading this step…
Loading this step…
Loading this step…
Loading this step…
Shares Cobalt-60 teletherapy, Linear accelerator machines: from Clinac to AI-imaging linacs, rings and radiosurgery units and the tag machines-wave3.
Shares Cobalt-60 teletherapy, Linear accelerator machines: from Clinac to AI-imaging linacs, rings and radiosurgery units and the tag machines-wave3.
Shares Linear accelerator machines: from Clinac to AI-imaging linacs, rings and radiosurgery units and the tag machines-wave3.
Shares Linear accelerator machines: from Clinac to AI-imaging linacs, rings and radiosurgery units and the tag machines-wave3.
Shares Linear accelerator machines: from Clinac to AI-imaging linacs, rings and radiosurgery units and the tag machines-wave3.
Shares Elekta, Radiotherapy roadmap: X-rays → shaped beams → fewer fractions, particles and FLASH, Surgery and radiotherapy cure most, get least and the tag machines-wave3.
Shares Elekta and the tag machines-wave3.
Shares Radiotherapy roadmap: X-rays → shaped beams → fewer fractions, particles and FLASH, Surgery and radiotherapy cure most, get least and the tag machines-wave3.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/